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Introduction. Chronic hepatitis remains a global public health 
problem. The importance of approaching this issue is imposed by 
the high prevalence and severity of the consequences, especially 
of parenteral hepatitis. The burden of chronic hepatitis falls on 
the shoulders of the medical system and is determined by the 
socio-economic impact of this disease, widespread distribution 
among all age groups, involvement in the epidemic process of 
people of reproductive and working age, and last but not least the 
costs of coverage, treatment of people infected with this virus. 
Globally, chronic hepatitis B and C remain the 2  leading cause 
of liver cirrhosis and liver carcinoma. 
 Purpose. Study of the global distribution and the particularities 
of the evolution of the epidemic process in chronic hepatitis. 
  Material and methods. A systematic literature review was 
conducted with the inclusion of 30 bibliographic sources published in 
the last 5 years, globally. 
 
Results. The morbidity chronic hepatitis of viral origin remains quite high, with a 
tendency to increase. The WHO estimates that globally about 257 million people 
are infected with HBV (Fig.1), 2-3% - HCV and 5% - HVD. Thus, every 9 of 10 
people are living with hepatitis B or C without knowing it. The data of official 
statistics in the Republic of Moldova highlights the high share of chronic hepatitis 
infections expressed by a total of 70 thousand patients, of which over 43 thousand 
are of viral origin. However, the rate of acute cases is declining due to the 
implementation of vaccination of newborns and people at risk. The 
WHO/UNICEF estimates that the National Immunization Coverage with the new 
vaccines including of hepatitis B, Haemophilus influenzae type b etc has 
accelerated (Fig.2). It can prevent the infection of 4.5 million children. According 
to the Ministry of Health, Labour and Social Protection in the period 2016-2019, 
approximately 15,637 people were definitively treated for hepatitis B, C and D, 
this is due to the implementation of a new treatment scheme for patients. 
  
Conclusions. Chronic hepatitis remains the leading cause of liver cirrhosis 
and hepatocellular carcinoma. Chronic liver deaths ranks 8th in global 
statistics. 
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Figure 2. Immunization Coverage in the world 
